0001799191-23-000040.txt : 20230830 0001799191-23-000040.hdr.sgml : 20230830 20230830150436 ACCESSION NUMBER: 0001799191-23-000040 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20230830 ITEM INFORMATION: Other Events FILED AS OF DATE: 20230830 DATE AS OF CHANGE: 20230830 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Oncology Institute, Inc. CENTRAL INDEX KEY: 0001799191 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39248 FILM NUMBER: 231224953 BUSINESS ADDRESS: STREET 1: 18000 STUDEBAKER RD STREET 2: SUITE 800 CITY: CERRITOS STATE: CA ZIP: 90703 BUSINESS PHONE: 562-735-3226 MAIL ADDRESS: STREET 1: 18000 STUDEBAKER RD STREET 2: SUITE 800 CITY: CERRITOS STATE: CA ZIP: 90703 FORMER COMPANY: FORMER CONFORMED NAME: DFP HEALTHCARE ACQUISITIONS CORP. DATE OF NAME CHANGE: 20200108 8-K 1 toi-20230830.htm 8-K toi-20230830
0001799191false00017991912023-08-302023-08-300001799191us-gaap:CommonStockMember2023-08-302023-08-300001799191us-gaap:WarrantMember2023-08-302023-08-30

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________________________
FORM 8-K
__________________________________________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

August 30, 2023
Date of Report (date of earliest event reported)
__________________________________________________________
The Oncology Institute, Inc.
(Exact name of registrant as specified in its charter)
__________________________________________________________
Delaware
(State or other jurisdiction of
incorporation or organization)
001-39248
(Commission File Number)
84-3562323
(I.R.S. Employer Identification Number)
18000 Studebaker Rd, Suite 800
Cerritos, California 90703
(Address of principal executive offices and zip code)
(562) 735-3226
(Registrant's telephone number, including area code)
__________________________________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol
Name of each exchange on which registered
Common stock, par value $0.001TOIThe Nasdaq Stock Market LLC
Redeemable warrants, each whole warrant exercisable for one share of Common stock, each at an exercise price of $11.50 per share
TOIIW
The Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 12b-2 of the Exchange Act.
Emerging growth company    ý
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o



Item 8.01. Other Events.

On August 28, 2023, the Board of Directors of The Oncology Institute, Inc. (the “Company”) approved a share repurchase program with authorization to purchase up to 2 million shares of the Company’s common stock, par value $0.0001 per share (“Common Stock”). The Company may repurchase shares from time to time through one or more securities broker-dealers, in open market purchases and negotiated purchases, in each case at price per share not to exceed $1.00. Shares repurchased by the Company pursuant to the share repurchase program shall be returned to the status of authorized but unissued shares of Common Stock.

In connection with the foregoing, on August 25, 2023, the Company entered into a limited consent (the “Limited Consent”), dated as of August 25, 2023, to that certain Facility Agreement, dated as of August 9, 2022 (as amended or otherwise modified from time to time, the “Facility Agreement”), by and among the Company, as borrower, certain of the Company’s subsidiaries from time to time party thereto as guarantors and Deerfield Partners, L.P., as agent for itself and the lenders (collectively, “Deerfield”). The Limited Consent permits the repurchase by the Company on or prior to September 16, 2023, of up to 2,000,000 shares of Common Stock in one or more open market or negotiated purchases, in each case at price per share not to exceed $1.00. The actual timing and amount of repurchases are subject to business and market conditions, corporate and regulatory requirements, stock price, acquisition opportunities and other factors. The Limited Consent does not obligate the Company to repurchase any amount of shares, and there can be no assurance that any shares will be repurchased. The Limited Consent also grants a one-time waiver under the Facility Agreement of certain delivery of any notice requirements.

The foregoing description of the Limited Consent does not purport to be complete and is qualified in its entirety by reference to the full text of the Limited Consent, a copy of which is attached hereto as Exhibit 10.1 and incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

(d) The following exhibits are being filed herewith:



Exhibit No.Description
10.1
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)
        



SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: August 30, 2023

The Oncology Institute, Inc.
By:
/s/ Mark Hueppelsheuser
Name:
Mark Hueppelsheuser
Title:
General Counsel

EX-101.SCH 2 toi-20230830.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 3 toi-20230830_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 4 toi-20230830_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Document Period End Date Document Period End Date Common Stock Common Stock [Member] Pre-commencement Tender Offer Pre-commencement Tender Offer Class of Stock [Domain] Class of Stock [Domain] Soliciting Material Soliciting Material City Area Code City Area Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Central Index Key Entity Central Index Key Entity Address, City or Town Entity Address, City or Town Security Exchange Name Security Exchange Name Title of 12(b) Security Title of 12(b) Security Written Communications Written Communications Document Information [Line Items] Document Information [Line Items] Local Phone Number Local Phone Number Trading Symbol Trading Symbol Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, State or Province Entity Address, State or Province Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Cover [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Redeemable Warrants Warrant [Member] Document Type Document Type Amendment Flag Amendment Flag Entity Ex Transition Period Entity Ex Transition Period Class of Stock [Axis] Class of Stock [Axis] Document Information [Table] Document Information [Table] Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Registrant Name Entity Registrant Name EX-101.PRE 5 toi-20230830_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 6 R1.htm IDEA: XBRL DOCUMENT v3.23.2
Cover Page
Aug. 30, 2023
Document Information [Line Items]  
Document Type 8-K
Document Period End Date Aug. 30, 2023
Entity Registrant Name The Oncology Institute, Inc.
Entity Incorporation, State or Country Code DE
Entity File Number 001-39248
Entity Tax Identification Number 84-3562323
Entity Address, Address Line One 18000 Studebaker Rd, Suite 800
Entity Address, City or Town Cerritos
Entity Address, State or Province CA
Entity Address, Postal Zip Code 90703
City Area Code 562
Local Phone Number 735-3226
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company true
Entity Ex Transition Period false
Entity Central Index Key 0001799191
Amendment Flag false
Common Stock  
Document Information [Line Items]  
Title of 12(b) Security Common stock, par value $0.001
Trading Symbol TOI
Security Exchange Name NASDAQ
Redeemable Warrants  
Document Information [Line Items]  
Title of 12(b) Security Redeemable warrants, each whole warrant exercisable for one share of Common stock, each at an exercise price of $11.50 per share
Trading Symbol TOIIW
Security Exchange Name NASDAQ
XML 7 toi-20230830_htm.xml IDEA: XBRL DOCUMENT 0001799191 2023-08-30 2023-08-30 0001799191 us-gaap:CommonStockMember 2023-08-30 2023-08-30 0001799191 us-gaap:WarrantMember 2023-08-30 2023-08-30 0001799191 false 8-K 2023-08-30 The Oncology Institute, Inc. DE 001-39248 84-3562323 18000 Studebaker Rd, Suite 800 Cerritos CA 90703 562 735-3226 false false false false Common stock, par value $0.001 TOI NASDAQ Redeemable warrants, each whole warrant exercisable for one share of Common stock, each at an exercise price of $11.50 per share TOIIW NASDAQ true false EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.2 html 3 23 1 false 2 0 false 0 false false R1.htm 0000001 - Document - Cover Page Sheet http://www.deitaxonomy.com/role/CoverPage Cover Page Cover 1 false false All Reports Book All Reports toi-20230830.htm toi-20230830.xsd toi-20230830_def.xml toi-20230830_lab.xml toi-20230830_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "toi-20230830.htm": { "axisCustom": 0, "axisStandard": 1, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 26 }, "contextCount": 3, "dts": { "definitionLink": { "local": [ "toi-20230830_def.xml" ] }, "inline": { "local": [ "toi-20230830.htm" ] }, "labelLink": { "local": [ "toi-20230830_lab.xml" ] }, "presentationLink": { "local": [ "toi-20230830_pre.xml" ] }, "schema": { "local": [ "toi-20230830.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] } }, "elementCount": 30, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2023": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 23, "memberCustom": 0, "memberStandard": 2, "nsprefix": "toi", "nsuri": "http://www.deitaxonomy.com/20230830", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "toi-20230830.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0000001 - Document - Cover Page", "menuCat": "Cover", "order": "1", "role": "http://www.deitaxonomy.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "toi-20230830.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 2, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.deitaxonomy.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.deitaxonomy.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2023", "xbrltype": "stringItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]", "terseLabel": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.deitaxonomy.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]", "terseLabel": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.deitaxonomy.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.deitaxonomy.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.deitaxonomy.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.deitaxonomy.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.deitaxonomy.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.deitaxonomy.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.deitaxonomy.com/role/CoverPage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.deitaxonomy.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.deitaxonomy.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period", "terseLabel": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.deitaxonomy.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.deitaxonomy.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.deitaxonomy.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.deitaxonomy.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.deitaxonomy.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.deitaxonomy.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.deitaxonomy.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.deitaxonomy.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.deitaxonomy.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.deitaxonomy.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.deitaxonomy.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.deitaxonomy.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.deitaxonomy.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.deitaxonomy.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "terseLabel": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.deitaxonomy.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.deitaxonomy.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrant [Member]", "terseLabel": "Redeemable Warrants" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.deitaxonomy.com/role/CoverPage" ], "xbrltype": "domainItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r7": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 14 0001799191-23-000040-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001799191-23-000040-xbrl.zip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end